Scarica l'app Stockscreener
1.54
9.22%
0.13
Pre-mercato:
1.46
-0.08
-5.19%
Fibrobiologics Inc Borsa (FBLG) Ultime notizie
Exclusive: FibroBiologics moves forward with human trial for diabetic foot ulcer therapy - MSN
The Psoriasis Clinical Trial Pipeline Boom as 90+ Companies are in the Race for Better Treatments | DelveInsight - GlobeNewswire Inc.
Market Outlook: Does FibroBiologics Inc have a competitive edge2026 Rallies & Risk Controlled Daily Plans - baoquankhu1.vn
FibroBiologics Presents Novel Thymus Organoid Platform to Combat Age-Related Immune Decline at Keystone Symposia on Aging and Immunity - Bitget
FibroBiologics presents preclinical data on thymic organoids By Investing.com - Investing.com India
FibroBiologics presents preclinical data on thymic organoids - Investing.com
FibroBiologics Presents Novel Thymus Organoid Platform to - GlobeNewswire
FibroBiologics ends Webster sublease early, updates principal office address - Investing.com UK
FibroBiologics, Inc. Files Form 8-K Current Report with SEC Detailing Company Information and Nasdaq Listing - Minichart
FibroBiologics, Inc. Files 8-K/A Amendment to Update Executive Office Address and Correct Item Disclosure – April 2026 7817 - Minichart
Fibrobiologics IncEnters Lease Termination Agreement With United Fire & Casualty On April 3, 2026SEC Filing - TradingView — Track All Markets
FibroBiologics ends Webster sublease early, updates principal office address By Investing.com - Investing.com South Africa
FibroBiologics (NASDAQ: FBLG) exits Webster lease early, eyeing $0.8M savings - Stock Titan
FibroBiologics Ends Texas Sublease, Consolidates Houston Operations - TipRanks
[SCHEDULE 13G] FibroBiologics, Inc. Passive Investment Disclosure (>5%) - Stock Titan
FibroBiologics (NASDAQ: FBLG) ends sublease to save $0.8M rent - Stock Titan
Analyst Downgrade: Is FibroBiologics Inc subject to activist investor interest2026 Opening Moves & AI Forecast for Swing Trade Picks - baoquankhu1.vn
Aug Patterns: Is FibroBiologics Inc subject to activist investor interest2026 Levels & Fast Moving Trade Plans - baoquankhu1.vn
Price to sales ratio of FibroBiologics, Inc. – FWB:SG00 - TradingView — Track All Markets
Price to sales ratio of FibroBiologics, Inc. – LSX:A426UV - TradingView
FibroBiologics, Inc. Financial Statements – LSX:A426UV - TradingView — Track All Markets
Aug Ideas: Is FibroBiologics Inc benefiting from interest rate changes2026 Stock Rankings & Advanced Swing Trade Entry Plans - baoquankhu1.vn
Market Review: Is FibroBiologics Inc benefiting from interest rate changes2026 Snapshot & Low Drawdown Trading Techniques - baoquankhu1.vn
FibroBiologics, Inc. Announces Reverse Stock Split and Certificate Amendment – SEC Form 8-K Filing Summary - Minichart
FibroBiologics Implements One-for-Twenty Reverse Stock Split - TipRanks
FibroBiologics (NASDAQ: FBLG) completes 1:20 reverse stock split - Stock Titan
FibroBiologics closes $3M public offering with warrants By Investing.com - Investing.com Canada
FibroBiologics Announces Closing of $3 Million Public Offering - Sahm
Fibrobiologics announces closing of $3 million public offering - marketscreener.com
Fibrobiologics Announces Closing Of $3 Million Public Offering - TradingView — Track All Markets
FibroBiologics Closes $3M Public Offering - National Today
FibroBiologics Announces Public Offering and Warrant Agreements - TipRanks
FibroBiologics Raises $2.5 Million Net in Public Offering Priced at $1.32, Adds Warrants Upside - TradingView — Track All Markets
FibroBiologics closes $3M public offering with warrants - Investing.com
FibroBiologics (NASDAQ: FBLG) closes $3M stock and warrant offering - Stock Titan
FibroBiologics, Inc. Common Stock (FBLG) Stock Price Today & Analysis - Gotrade
FibroBiologics (NASDAQ: FBLG) sells shares and warrants; reverse split in place - Stock Titan
FibroBiologics, Inc. Announces Pricing of Public Offering for 2.27 Million Shares and Warrants - Moomoo
FBLG: Advancing Fibroblast Therapy on Multiple Fronts - Yahoo Finance
FibroBiologics manufactures first batch of CYWC628 drug product for trials - TipRanks
FibroBiologics prices $3M public offering at $1.32/share By Investing.com - Investing.com Australia
FibroBiologics completes first CYWC628 batch for clinical trials By Investing.com - Investing.com South Africa
FibroBiologics prices $3M public offering at $1.32/share - Investing.com
FibroBiologics Announces Pricing of $3 Million Public Offering - The Manila Times
After a $3M raise, FibroBiologics targets working capital needs - Stock Titan
FibroBiologics Completes Manufacturing of Diabetic Foot Ulcer Drug - National Today
2.69%
0.25%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):